Sequent Scientific picks up 5.8% stake in Shasun Pharmaceuticals

10 Jun 2014 Evaluate

Sequent Scientific has acquired 35,00,000 equity shares in Shasun Pharmaceuticals through preferential allotment mode, for around Rs 38.5 crore. Following the acquisition, the Bangalore-based company would have 5.82% share in Shasun Pharmaceuticals’ total equity shares.

Earlier, Sequent Scientific, which has launched a joint venture firm with Shasun Pharma some time back, has been planning to pick up a minority stake of around 16% in the company with an investment of around Rs 116 crore.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×